APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fish-Oil Based Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Fish-Oil Based Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025192 pages

Choose your research edition.

Industry ResearchFish-Oil Based Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Fish-Oil Based Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Fish-Oil Based Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fish-Oil Based Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fish-Oil Based Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Fish-Oil Based Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fish-Oil Based Drugs include Aker Biomarine, BASF SE, Cellana, Clover Corporation, Croda International PLC, GC Rieber Oil, Omega Protein Corporation, Pharma Marine and Solutex GC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fish-Oil Based Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fish-Oil Based Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fish-Oil Based Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fish-Oil Based Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Fish-Oil Based Drugs Segment by Company

Aker Biomarine

BASF SE

Cellana

Clover Corporation

Croda International PLC

GC Rieber Oil

Omega Protein Corporation

Pharma Marine

Solutex GC

Stepan Company

United Laboratories

Fish-Oil Based Drugs Segment by Type

Salmon

Mackerel

Tuna

Herring

Others

Fish-Oil Based Drugs Segment by Application

Stroke

Dysmenorrhea

Rheumatoid Arthritis

Raynaud's Syndrome

Coronary Heart Disease (CHD)

Other

Fish-Oil Based Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fish-Oil Based Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fish-Oil Based Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fish-Oil Based Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fish-Oil Based Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fish-Oil Based Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fish-Oil Based Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fish-Oil Based Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fish-Oil Based Drugs Industry Trends Table 2. Fish-Oil Based Drugs Industry Drivers Table 3. Fish-Oil Based Drugs Industry Opportunities and Challenges Table 4. Fish-Oil Based Drugs Industry Restraints Table 5. Global Fish-Oil Based Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fish-Oil Based Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fish-Oil Based Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Fish-Oil Based Drugs Sales Market Share by Manufacturers Table 9. Global Fish-Oil Based Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Fish-Oil Based Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fish-Oil Based Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fish-Oil Based Drugs Manufacturers, Product Type & Application Table 13. Global Fish-Oil Based Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fish-Oil Based Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Salmon Table 17. Major Manufacturers of Mackerel Table 18. Major Manufacturers of Tuna Table 19. Major Manufacturers of Herring Table 20. Major Manufacturers of Others Table 21. Global Fish-Oil Based Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Fish-Oil Based Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Fish-Oil Based Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Fish-Oil Based Drugs Sales Market Share by Type (2021-2026) Table 25. Global Fish-Oil Based Drugs Sales Market Share by Type (2027-2032) Table 26. Global Fish-Oil Based Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Fish-Oil Based Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Fish-Oil Based Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Fish-Oil Based Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Fish-Oil Based Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Stroke Table 32. Major Manufacturers of Dysmenorrhea Table 33. Major Manufacturers of Rheumatoid Arthritis Table 34. Major Manufacturers of Raynaud's Syndrome Table 35. Major Manufacturers of Coronary Heart Disease (CHD) Table 36. Major Manufacturers of Other Table 37. Global Fish-Oil Based Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Fish-Oil Based Drugs Sales by Application (2021-2026) & (K Units) Table 39. Global Fish-Oil Based Drugs Sales by Application (2027-2032) & (K Units) Table 40. Global Fish-Oil Based Drugs Sales Market Share by Application (2021-2026) Table 41. Global Fish-Oil Based Drugs Sales Market Share by Application (2027-2032) Table 42. Global Fish-Oil Based Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Fish-Oil Based Drugs Revenue by Application (2021-2026) & (K Units) Table 44. Global Fish-Oil Based Drugs Revenue by Application (2027-2032) & (K Units) Table 45. Global Fish-Oil Based Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Fish-Oil Based Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Fish-Oil Based Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Fish-Oil Based Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Fish-Oil Based Drugs Sales Market Share by Region (2021-2026) Table 50. Global Fish-Oil Based Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Fish-Oil Based Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Fish-Oil Based Drugs Sales by Country (2021-2026) & (K Units) Table 54. North America Fish-Oil Based Drugs Sales by Country (2027-2032) & (K Units) Table 55. Europe Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Fish-Oil Based Drugs Sales by Country (2021-2026) & (K Units) Table 57. Europe Fish-Oil Based Drugs Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Fish-Oil Based Drugs Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Fish-Oil Based Drugs Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Fish-Oil Based Drugs Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Fish-Oil Based Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Fish-Oil Based Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Fish-Oil Based Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Fish-Oil Based Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Fish-Oil Based Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Fish-Oil Based Drugs Revenue Market Share by Region (2027-2032) Table 69. Aker Biomarine Company Information Table 70. Aker Biomarine Business Overview Table 71. Aker Biomarine Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Aker Biomarine Fish-Oil Based Drugs Product Portfolio Table 73. Aker Biomarine Recent Development Table 74. BASF SE Company Information Table 75. BASF SE Business Overview Table 76. BASF SE Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BASF SE Fish-Oil Based Drugs Product Portfolio Table 78. BASF SE Recent Development Table 79. Cellana Company Information Table 80. Cellana Business Overview Table 81. Cellana Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Cellana Fish-Oil Based Drugs Product Portfolio Table 83. Cellana Recent Development Table 84. Clover Corporation Company Information Table 85. Clover Corporation Business Overview Table 86. Clover Corporation Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Clover Corporation Fish-Oil Based Drugs Product Portfolio Table 88. Clover Corporation Recent Development Table 89. Croda International PLC Company Information Table 90. Croda International PLC Business Overview Table 91. Croda International PLC Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Croda International PLC Fish-Oil Based Drugs Product Portfolio Table 93. Croda International PLC Recent Development Table 94. GC Rieber Oil Company Information Table 95. GC Rieber Oil Business Overview Table 96. GC Rieber Oil Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. GC Rieber Oil Fish-Oil Based Drugs Product Portfolio Table 98. GC Rieber Oil Recent Development Table 99. Omega Protein Corporation Company Information Table 100. Omega Protein Corporation Business Overview Table 101. Omega Protein Corporation Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio Table 103. Omega Protein Corporation Recent Development Table 104. Pharma Marine Company Information Table 105. Pharma Marine Business Overview Table 106. Pharma Marine Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Pharma Marine Fish-Oil Based Drugs Product Portfolio Table 108. Pharma Marine Recent Development Table 109. Solutex GC Company Information Table 110. Solutex GC Business Overview Table 111. Solutex GC Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Solutex GC Fish-Oil Based Drugs Product Portfolio Table 113. Solutex GC Recent Development Table 114. Stepan Company Company Information Table 115. Stepan Company Business Overview Table 116. Stepan Company Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Stepan Company Fish-Oil Based Drugs Product Portfolio Table 118. Stepan Company Recent Development Table 119. United Laboratories Company Information Table 120. United Laboratories Business Overview Table 121. United Laboratories Fish-Oil Based Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. United Laboratories Fish-Oil Based Drugs Product Portfolio Table 123. United Laboratories Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Fish-Oil Based Drugs Distributors List Table 127. Fish-Oil Based Drugs Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Fish-Oil Based Drugs Product Image Figure 2. Global Fish-Oil Based Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fish-Oil Based Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Fish-Oil Based Drugs Sales (2021-2032) & (K Units) Figure 5. Global Fish-Oil Based Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fish-Oil Based Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Salmon Image Figure 9. Mackerel Image Figure 10. Tuna Image Figure 11. Herring Image Figure 12. Others Image Figure 13. Global Fish-Oil Based Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Fish-Oil Based Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Fish-Oil Based Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Fish-Oil Based Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Fish-Oil Based Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fish-Oil Based Drugs Revenue Market Share by Type (2021-2032) Figure 19. Stroke Image Figure 20. Dysmenorrhea Image Figure 21. Rheumatoid Arthritis Image Figure 22. Raynaud's Syndrome Image Figure 23. Coronary Heart Disease (CHD) Image Figure 24. Other Image Figure 25. Global Fish-Oil Based Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Fish-Oil Based Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Fish-Oil Based Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Fish-Oil Based Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Fish-Oil Based Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Fish-Oil Based Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Fish-Oil Based Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Fish-Oil Based Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Fish-Oil Based Drugs Sales Market Share by Country (2021-2032) Figure 45. China Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Fish-Oil Based Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Fish-Oil Based Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Fish-Oil Based Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Fish-Oil Based Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Fish-Oil Based Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Fish-Oil Based Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Fish-Oil Based Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Fish-Oil Based Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Fish-Oil Based Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Fish-Oil Based Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Salmon
  • Mackerel
  • Tuna
  • Herring
  • Others
Applications
  • Stroke
  • Dysmenorrhea
  • Rheumatoid Arthritis
  • Raynaud's Syndrome
  • Coronary Heart Disease (CHD)
  • Other
Companies covered
  • Aker Biomarine
  • BASF SE
  • Cellana
  • Clover Corporation
  • Croda International PLC
  • GC Rieber Oil
  • Omega Protein Corporation
  • Pharma Marine
  • Solutex GC
  • Stepan Company
  • United Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fish-Oil Based Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fish-Oil Based Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fish-Oil Based Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fish-Oil Based Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fish-Oil Based Drugs Market Dynamics
  1. 2.1 Fish-Oil Based Drugs Industry Trends
  2. 2.2 Fish-Oil Based Drugs Industry Drivers
  3. 2.3 Fish-Oil Based Drugs Industry Opportunities and Challenges
  4. 2.4 Fish-Oil Based Drugs Industry Restraints
3 Fish-Oil Based Drugs Market by Manufacturers
  1. 3.1 Global Fish-Oil Based Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fish-Oil Based Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fish-Oil Based Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fish-Oil Based Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fish-Oil Based Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fish-Oil Based Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Fish-Oil Based Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fish-Oil Based Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fish-Oil Based Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fish-Oil Based Drugs Tier 1, Tier 2, and Tier 3
4 Fish-Oil Based Drugs Market by Type
  1. 4.1 Fish-Oil Based Drugs Type Introduction
  2. 4.1.1 Salmon
  3. 4.1.2 Mackerel
  4. 4.1.3 Tuna
  5. 4.1.4 Herring
  6. 4.1.5 Others
  7. 4.2 Global Fish-Oil Based Drugs Sales by Type
  8. 4.2.1 Global Fish-Oil Based Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Fish-Oil Based Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Fish-Oil Based Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Fish-Oil Based Drugs Revenue by Type
  12. 4.3.1 Global Fish-Oil Based Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Fish-Oil Based Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Fish-Oil Based Drugs Revenue Market Share by Type (2021-2032)
5 Fish-Oil Based Drugs Market by Application
  1. 5.1 Fish-Oil Based Drugs Application Introduction
  2. 5.1.1 Stroke
  3. 5.1.2 Dysmenorrhea
  4. 5.1.3 Rheumatoid Arthritis
  5. 5.1.4 Raynaud's Syndrome
  6. 5.1.5 Coronary Heart Disease (CHD)
  7. 5.1.6 Other
  8. 5.2 Global Fish-Oil Based Drugs Sales by Application
  9. 5.2.1 Global Fish-Oil Based Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Fish-Oil Based Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global Fish-Oil Based Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global Fish-Oil Based Drugs Revenue by Application
  13. 5.3.1 Global Fish-Oil Based Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Fish-Oil Based Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global Fish-Oil Based Drugs Revenue Market Share by Application (2021-2032)
6 Global Fish-Oil Based Drugs Sales by Region
  1. 6.1 Global Fish-Oil Based Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fish-Oil Based Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Fish-Oil Based Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Fish-Oil Based Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fish-Oil Based Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fish-Oil Based Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fish-Oil Based Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fish-Oil Based Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fish-Oil Based Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fish-Oil Based Drugs Revenue by Region
  1. 7.1 Global Fish-Oil Based Drugs Revenue by Region
  2. 7.1.1 Global Fish-Oil Based Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fish-Oil Based Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Fish-Oil Based Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Fish-Oil Based Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fish-Oil Based Drugs Revenue (2021-2032)
  8. 7.2.2 North America Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fish-Oil Based Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fish-Oil Based Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fish-Oil Based Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fish-Oil Based Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aker Biomarine
  2. 8.1.1 Aker Biomarine Company Information
  3. 8.1.2 Aker Biomarine Business Overview
  4. 8.1.3 Aker Biomarine Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aker Biomarine Fish-Oil Based Drugs Product Portfolio
  6. 8.1.5 Aker Biomarine Recent Developments
  7. 8.2 BASF SE
  8. 8.2.1 BASF SE Company Information
  9. 8.2.2 BASF SE Business Overview
  10. 8.2.3 BASF SE Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BASF SE Fish-Oil Based Drugs Product Portfolio
  12. 8.2.5 BASF SE Recent Developments
  13. 8.3 Cellana
  14. 8.3.1 Cellana Company Information
  15. 8.3.2 Cellana Business Overview
  16. 8.3.3 Cellana Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cellana Fish-Oil Based Drugs Product Portfolio
  18. 8.3.5 Cellana Recent Developments
  19. 8.4 Clover Corporation
  20. 8.4.1 Clover Corporation Company Information
  21. 8.4.2 Clover Corporation Business Overview
  22. 8.4.3 Clover Corporation Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Clover Corporation Fish-Oil Based Drugs Product Portfolio
  24. 8.4.5 Clover Corporation Recent Developments
  25. 8.5 Croda International PLC
  26. 8.5.1 Croda International PLC Company Information
  27. 8.5.2 Croda International PLC Business Overview
  28. 8.5.3 Croda International PLC Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Croda International PLC Fish-Oil Based Drugs Product Portfolio
  30. 8.5.5 Croda International PLC Recent Developments
  31. 8.6 GC Rieber Oil
  32. 8.6.1 GC Rieber Oil Company Information
  33. 8.6.2 GC Rieber Oil Business Overview
  34. 8.6.3 GC Rieber Oil Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GC Rieber Oil Fish-Oil Based Drugs Product Portfolio
  36. 8.6.5 GC Rieber Oil Recent Developments
  37. 8.7 Omega Protein Corporation
  38. 8.7.1 Omega Protein Corporation Company Information
  39. 8.7.2 Omega Protein Corporation Business Overview
  40. 8.7.3 Omega Protein Corporation Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio
  42. 8.7.5 Omega Protein Corporation Recent Developments
  43. 8.8 Pharma Marine
  44. 8.8.1 Pharma Marine Company Information
  45. 8.8.2 Pharma Marine Business Overview
  46. 8.8.3 Pharma Marine Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharma Marine Fish-Oil Based Drugs Product Portfolio
  48. 8.8.5 Pharma Marine Recent Developments
  49. 8.9 Solutex GC
  50. 8.9.1 Solutex GC Company Information
  51. 8.9.2 Solutex GC Business Overview
  52. 8.9.3 Solutex GC Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Solutex GC Fish-Oil Based Drugs Product Portfolio
  54. 8.9.5 Solutex GC Recent Developments
  55. 8.10 Stepan Company
  56. 8.10.1 Stepan Company Company Information
  57. 8.10.2 Stepan Company Business Overview
  58. 8.10.3 Stepan Company Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Stepan Company Fish-Oil Based Drugs Product Portfolio
  60. 8.10.5 Stepan Company Recent Developments
  61. 8.11 United Laboratories
  62. 8.11.1 United Laboratories Company Information
  63. 8.11.2 United Laboratories Business Overview
  64. 8.11.3 United Laboratories Fish-Oil Based Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 United Laboratories Fish-Oil Based Drugs Product Portfolio
  66. 8.11.5 United Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fish-Oil Based Drugs Value Chain Analysis
  2. 9.1.1 Fish-Oil Based Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fish-Oil Based Drugs Production Mode & Process
  6. 9.2 Fish-Oil Based Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fish-Oil Based Drugs Distributors
  9. 9.2.3 Fish-Oil Based Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst